Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis

American Journal of Gastroenterology

Volumn 103, Issue 7, 2008, Pages 1682-1688

  Wong, Vincent Wai Sun ^b   Wong, Grace Lai Hung ^b   Chim, Angel Mei Ling ^b   Tse, Ada Mei Ling ^b   Tsang, Steven Woon Choy ^c   Hui, Alex Yui ^b   Choi, Paul Cheung Lung ^b   Chan, Anthony Wing Hung ^b   So, Wing Yee ^b   Chan, Francis Ka Leung ^b   Sung, Joseph Jao Yao ^b   Chan, Henry Lik Yuen ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c TSEUNG KWAN O HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD ANALYSIS; CHINESE; FEMALE; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PREVALENCE; PRIORITY JOURNAL; CHINA; FATTY LIVER; LIVER CIRRHOSIS; MIDDLE AGED; PROSPECTIVE STUDY;

CHINA; FATTY LIVER; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES;

EID: 50649109837     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.01933.x     Document Type: Article

References (25)

1. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology 2006;43:S99-112.
2. Villanova N, Moscatiello S, Ramilli S, et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005;42:473-80.
3. Targher G, Bertolini L, Padovani R, et al. Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: Role of visceral fat accumulation. Diabetes Care 2004;27:2498-500.
4. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: From crypto- genic cirrhosis to hepatocellular carcinoma. Gastroenterol- ogy 2002;123:134-40.
5. Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology 2005;129:113-21.
6. Fan JG, Zhu J, Li XJ, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 2005;43:508-14.
7. Wong VW, Chan HL, Hui AY, et al. Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese. Aliment Pharmacol Ther 2004;20:45-9.
8. Hui AY, Wong VW, Chan HL, et al. Histological progression of non-alcoholic fatty liver disease in Chinese patients. Aliment Pharmacol Ther 2005;21:407-13.
9. Ekstedt M, Franzen LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865-73.
10. Chan HL, de Silva HJ, Leung NW, et al. How should we manage patients with non-alcoholic fatty liver disease in 2007? J Gastroenterol Hepatol 2007;22:801-8.
11. Guha IN, Parkes J, Roderick PR, et al. Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease. Gut 2006;55:1650-60.
12. Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007;45:846-54.
13. Wong VW, Hui AY, Tsang SW, et al. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2006;4:1154-61.
14. American Diabetic Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29(Suppl1):S43-8.
15. Wai CT, Greenson JK, Fontana RJ, et al. A simple nonin- vasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-26.
16. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121:91-100.
17. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-74.
18. Tsang SW, Ng WF, Wu BP, et al. Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis. J Gas- troenterol Hepatol 2006;21:116-21.
19. Malik A, Cheah PL, Hilmi IN, et al. Non-alcoholic fatty liver disease in Malaysia: A demographic, anthropometric, metabolic and histological study. J Dig Dis 2007;8:58-64.
20. Sheth SG, Flamm SL, Gordon FD, et al. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1998;93:44-8.
21. Park GJ, Lin BP, Ngu MC, et al. Aspartate aminotransferase: Alanine aminotransferase ratio in chronic hepatitis C infection: Is it a useful predictor of cirrhosis? J Gastroenterol Hepatol 2000;15:386-90.
22. Giannini E, Risso D, Botta F, et al. Validity and clinical utility of the aspartate aminotransferase-alanine aminotrans- ferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med 2003;163:218-24.
23. Ganne-Carrie N, Ziol M, de Ledinghen V, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006;44:1511-7.
24. YonedaM, FujitaK, InamoriM, etal. Transientelastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut 2007;56:1330-1.
25. Kettaneh A, Marcellin P, Douvin C, et al. Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: A prospective study of 935 patients. J Hepatol 2007;46:628-34.